Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma

被引：1
|
作者：
Powles, Thomas [1 ]
Burgents, Joseph E. [2 ]
Xu, Lei [2 ]
Choueiri, Toni K. [3 ]
机构：
[1] Queen Mary Univ London, St Bartholomews Hosp, Barts Canc Inst, Expt Canc Med Ctr, London EC1M 6BQ, England
[2] Merck & Co Inc, Rahway, NJ USA
[3] Dana Farber Canc Inst, Boston, MA USA
来源：
LANCET ONCOLOGY | 2023年 / 24卷 / 01期
关键词：
D O I：
10.1016/S1470-2045(22)00740-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E1 / E2
页数：2
相关论文
共 50 条
  • [21] Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
    Choueiri, T. K.
    Tomczak, P.
    Park, S. H.
    Venugopal, B.
    Ferguson, T.
    Chang, Y. -H.
    Hajek, J.
    Symeonides, S. N.
    Lee, J. L.
    Sarwar, N.
    Thiery-Vuillemin, A.
    Gross-Goupil, M.
    Mahave, M.
    Haas, N. B.
    Sawrycki, P.
    Gurney, H.
    Chevreau, C.
    Melichar, B.
    Kopyltsov, E.
    Alva, A.
    Burke, J. M.
    Doshi, G.
    Topart, D.
    Oudard, S.
    Hammers, H.
    Kitamura, H.
    Bedke, J.
    Perini, R. F.
    Zhang, P.
    Imai, K.
    Willemann-Rogerio, J.
    Quinn, D. I.
    Powles, T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (08): : 683 - 694
  • [22] Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma
    Choueiri, T. K.
    Tomczak, P.
    Park, S. H.
    Venugopal, B.
    Ferguson, T.
    Symeonides, S. N.
    Hajek, J.
    Chang, Y-H
    Lee, J-L
    Sarwar, N.
    Haas, N. B.
    Gurney, H.
    Sawrycki, P.
    Mahave, M.
    Gross-Goupil, M.
    Zhang, T.
    Burke, J. M.
    Doshi, G.
    Melichar, B.
    Kopyltsov, E.
    Alva, A.
    Oudard, S.
    Topart, D.
    Hammers, H.
    Kitamura, H.
    McDermott, D. F.
    Silva, A.
    Winquist, E.
    Cornell, J.
    Elfiky, A.
    Burgents, J. E.
    Perini, R. F.
    Powles, T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (15): : 1359 - 1371
  • [23] Comparative survival outcomes of non-clear cell and clear cell renal cell carcinomas with indications for adjuvant pembrolizumab.
    Musso, Giacomo
    Meagher, Margaret F.
    Yuen, Kit L.
    Ahdoot, Aaron
    Puri, Dhruv
    Dabbas, Mai
    Guer, Melis
    Birouty, Natalie
    Patil, Dattatraya H.
    Tanaka, Hajime
    Kobayashi, Masaki
    Fukuda, Shohei
    Montorsi, Francesco
    Briganti, Alberto
    Salonia, Andrea
    Capitanio, Umberto
    Larcher, Alessandro
    Fujii, Yasuhisa
    Master, Viraj A.
    Derweesh, Ithaar H.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL) : 515 - 515
  • [24] Adjuvant therapy of uterine clear cell carcinoma: a review
    Xu, Yiqing
    Hanna, Rabbie K.
    Elshaikh, Mohamed A.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2016, 293 (03) : 485 - 492
  • [25] Adjuvant therapy of uterine clear cell carcinoma: a review
    Yiqing Xu
    Rabbie K. Hanna
    Mohamed A. Elshaikh
    Archives of Gynecology and Obstetrics, 2016, 293 : 485 - 492
  • [26] Update on systemic therapy for clear cell renal cell carcinoma
    Josef Mühlmann
    memo - Magazine of European Medical Oncology, 2023, 16 : 38 - 41
  • [27] Update on systemic therapy for clear cell renal cell carcinoma
    Muehlmann, Josef
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (01) : 38 - 41
  • [28] New drug approval: Adjuvant Pembrolizumab in clear-cell renal-cell carcinoma at high risk for recurrence after nephrectomy
    Brunet, Maxime
    Malouf, Gabriel G.
    BULLETIN DU CANCER, 2022, 109 (09) : 875 - 876
  • [29] LITESPARK-022: A phase 3 study of pembrolizumab plus belzutifan as adjuvant treatment of clear cell renal cell carcinoma (ccRCC)
    Choueiri, Toni K.
    Bedke, Jens
    Karam, Jose A.
    Mckay, Rana R.
    Motzer, Robert J.
    Pal, Sumanta K.
    Suarez, Cristina
    Uzzo, Robert
    Liu, Hong
    Burgents, Joseph E.
    Sharma, Manish
    Powles, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [30] Adjuvant interferon therapy for renal cell carcinoma
    Aso, Y
    Homma, Y
    Koyanagi, T
    Kumamoto, Y
    Orikasa, S
    Nakada, H
    Sato, S
    Sakata, Y
    Yamanaka, H
    Koiso, K
    Shimazaki, A
    Tazaki, H
    Machida, T
    Okada, K
    Osada, H
    Kawai, T
    Umeda, T
    Hosaka, M
    Satomi, Y
    Ogawa, A
    Kawabe, K
    Miyake, K
    Ohshima, S
    Ariyoshi, H
    Kawada, Y
    Hisazumi, H
    Tomoyoshi, T
    Yoshida, O
    Watanabe, H
    Okuyama, A
    Kishimoto, T
    Kurita, T
    Kotake, T
    Okajima, E
    Kamidono, S
    Ikoma, F
    Ohmori, H
    Usui, H
    Fujita, Y
    Kumazawa, J
    Ueda, S
    AKTUELLE UROLOGIE, 1996, 27 : 9 - 12
12345